phospho-Bcl-xL (Thr115) Polyclonal Antibody, APC-Cy5.5 Conjugated, APC/Cy5.5, Rabbit

Artikelnummer: BSS-BS-5234R-APC-CY5.5
Artikelname: phospho-Bcl-xL (Thr115) Polyclonal Antibody, APC-Cy5.5 Conjugated, APC/Cy5.5, Rabbit
Artikelnummer: BSS-BS-5234R-APC-CY5.5
Hersteller Artikelnummer: bs-5234R-APC-Cy5.5
Alternativnummer: BSS-BS-5234R-APC-CY5.5-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Spezies Reaktivität: Human, Mouse, Rat
Konjugation: APC/Cy5.5
Alternative Synonym: BCLX, BCL2L, BCLXL, BCLXS, Bcl-X, bcl-xL, bcl-xS, PPP1R52, BCL-XL/S, Bcl-2-like protein 1, Bcl2-L-1, Apoptosis regulator Bcl-X, BCL2L1
Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis. Isoform Bcl-X(L) also regulates presynaptic plasticity, including neurotransmitter release and recovery, number of axonal mitochondria as well as size and number of synaptic vesicle clusters. During synaptic stimulation, increases ATP availability from mitochondria through regulation of mitochondrial membrane ATP synthase F(1)F(0) activity and regulates endocytic vesicle retrieval in hippocampal neurons through association with DMN1L and stimulation of its GTPase activity in synaptic vesicles. Isoform Bcl-X(S) promotes apoptosis.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 598
UniProt: Q07817
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic phosphopeptide derived from human BCL2L1 around the phosphorylation site of Thr115
Target-Kategorie: phospho-Bcl-xL (Thr115)
Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)